The current valuation score of Kamada Ltd is 8.10, ranking 107 out of 157 in the Pharmaceuticals industry. Its current P/E ratio is 20.52, which is 270.85% below the recent high of 76.10 and 625.11% above the recent low of -107.76.
P/E
Relevant data have not been disclosed by the company yet.
P/B
Relevant data have not been disclosed by the company yet.
P/S
Relevant data have not been disclosed by the company yet.
P/CF
Relevant data have not been disclosed by the company yet.